
Imagene AI, a provider of AI-based precision medicine for cancer, has raised $21.5 million in funding. The investors include Blumberg Capital and Larry Ellison.
Source: Press Release
Imagene AI, a provider of AI-based precision medicine for cancer, has raised $21.5 million in funding.
Imagene AI, a provider of AI-based precision medicine for cancer, has raised $21.5 million in funding. The investors include Blumberg Capital and Larry Ellison.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination